wikinvest Sr. Director
|last edit 2522||days ago|
Continuing the expansion of our set of tools here at MagicDiligence, today I'm rolling out a new data point: the 3 year average revenue growth metric.
The addition of this metric answers a common question myself (and hopefully many of you) ask when looking at Magic-style stocks: "sure its cheap, but is the company growing?".
There are few things more powerful for stock... read more
Most of the action in the official Magic Formula screens this past week was "on the margin", meaning we don't have a lot of entirely new names.
One entirely new name is Xenon Pharmaceuticals (XENE), a development stage pharmaceutical firm with relatively steady revenues. That one could be worth a closer look.
Here are the full lists...
Entering the 50 over 50... read more
One of the big reasons for revamping our screening tools was to be able to provide a Magic Formula?-like ranking using free cash flow yield instead of earnings yield.
Most value investors will tell you that free cash flow is the purest measure of a company's success. The purpose of a business is to use assets to generate cash, cash which can be used to reward owners... read more